Paper16044444
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.
Gertz MA and 12 others. Am J Hematol, 2005. Cited by 1,173 papers, by iCite.
Cite this record
ConductScience Library. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Papers, record 16044444. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16044444
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyloid | Major topic |
| Amyloidosis | Major topic |
| Immunoglobulin Light Chains | Major topic |
| France | |
| Humans | |
| Organ Specificity |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02245867 | Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL Amyloidosis | Background |
Source ClinicalTrials.gov
Cited by512
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,173 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42894083 | Expanding role of nuclear medicine in cardiac amyloidosis: insights from the EJNMMI collection. | EJNMMI Rep | 2026 | https://conductscience.org/library/papers/42894083 | PubMed |
| 42855647 | Myocardial work in light-chain and transthyretin-related amyloidosis with preserved ejection fraction: a cardiovascular magnetic resonance study. | Insights Imaging | 2026 | https://conductscience.org/library/papers/42855647 | PubMed |
| 42780369 | Sequential Autologous Stem Cell Transplantation and Ciltacabtagene Autoleucel for Concurrent Multiple Myeloma and Presumptive Immunoglobulin Heavy- and Light-Chain Amyloidosis in a Patient With Systemic Lupus Erythematosus. | Cureus | 2026 | https://conductscience.org/library/papers/42780369 | PubMed |
| 42709342 | Amyloidosis & Advanced Heart Failure: When to Consider Cardiac Transplantation and What are the Results? | Curr Heart Fail Rep | 2026 | https://conductscience.org/library/papers/42709342 | PubMed |
| 42696049 | Evaluation of echocardiographic features and cardiac biomarkers in patients with AA amyloidosis: a retrospective comparative study with patients with al amyloidosis and hypertrophic cardiomyopathy. | Rheumatol Int | 2026 | https://conductscience.org/library/papers/42696049 | PubMed |
| 42633047 | Delayed kidney response in AL amyloidosis: prevalence and clinical significance. | Clin Kidney J | 2026 | https://conductscience.org/library/papers/42633047 | PubMed |
| 42597282 | A rare coexistence of immunoglobulin light chain amyloidosis and POEMS syndrome manifesting as refractory heart failure: a case report and literature review. | Front Immunol | 2026 | https://conductscience.org/library/papers/42597282 | PubMed |
| 42566913 | Limited duration of dexamethasone in newly diagnosed AL amyloidosis: impact on response, toxicity, and survival. | Ann Med | 2026 | https://conductscience.org/library/papers/42566913 | PubMed |
| 42559781 | Cardiac Tamponade From Lymphocytic Constrictive Pericarditis in Primary AL Amyloidosis Without Myocardial Involvement. | JACC Case Rep | 2026 | https://conductscience.org/library/papers/42559781 | PubMed |
| 42535167 | Clinicopathological Characteristics and Prognostic Implications of Periodic Acid-Schiff-Positive Amyloid Deposits in Renal AL Amyloidosis. | Kidney Dis (Basel) | 2026 | https://conductscience.org/library/papers/42535167 | PubMed |
| 42459135 | What's liver got to do with it? Hepatic response and survival in AL amyloidosis. | Haematologica | 2026 | https://conductscience.org/library/papers/42459135 | PubMed |
| 42437238 | Cholestatic Jaundice Without Hepatomegaly as the Initial Manifestation of Hepatic Amyloid Light-Chain (AL) Amyloidosis: A Case of Rapid Multiorgan Failure. | Cureus | 2026 | https://conductscience.org/library/papers/42437238 | PubMed |
| 42332218 | Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/42332218 | PubMed |
| 42322078 | Long-Term Outcomes of Mayo Stage IIIb AL Amyloidosis Treated With Daratumumab-Based Frontline Therapy. | Am J Hematol | 2026 | https://conductscience.org/library/papers/42322078 | PubMed |
| 42311430 | Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid Diseases. | Hemasphere | 2026 | https://conductscience.org/library/papers/42311430 | PubMed |
| 42258481 | Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates. | CA Cancer J Clin | 2026 | https://conductscience.org/library/papers/42258481 | PubMed |
| 42252535 | Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis. | Am J Hematol | 2026 | https://conductscience.org/library/papers/42252535 | PubMed |
| 42234146 | When AL amyloidosis meets the liver: integrating clinical insight and current understanding. | Ann Hematol | 2026 | https://conductscience.org/library/papers/42234146 | PubMed |
| 42149416 | Daratumumab-based therapy in systemic AL amyloidosis including advanced cardiac involvement: a single center study. | Int J Hematol | 2026 | https://conductscience.org/library/papers/42149416 | PubMed |
| 41994108 | Risk of AL Amyloidosis is Associated with Degree of Free Light Chain Elevation and Duration of Exposure. | Res Sq | 2026 | https://conductscience.org/library/papers/41994108 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16044444
GET https://conductscience.org/api/papers/v1/16044444/cited_by?page=2